CSL Ltd (CSLLY) Q2 2024 Earnings Call Transcript

CSL Ltd (OTCQX:CSLLY) Q2 2024 Earnings Conference Call February 12, 2024 7:00 PM ET Company Participants Mark Dehring – Head, IR Paul McKenzie – MD, CEO & Executive Director William Mezzanotte – EVP & Head, Research and Development Herve Gisserot – Chief Commercial Officer, Vifor Pharma AG Andy Schmeltz – EVP, CSL Behring Business Unit…

Read More